Oncology & Cancer

Researchers share insights on the evolution of proton radiotherapy

In a review article published in The Lancet Oncology, Susu Yan, Ph.D., and Thomas Bortfeld, Ph.D., from the Biophysics Division of MGH's Department of Radiation Oncology, and co-authors describe the evolution of proton therapy ...

Medical research

Epigenetic drugs in the mission to beat rare cancers

Only one in 100,000 people suffer from a pheochromocytoma, a tumor of the adrenal gland. If the tumor has already metastasized, a radioactive compound can be used to detect malignant cells that have spread to other parts ...

page 11 from 40